Content Library | Clinical Trial Supply Forum

Take a peek at who joined us in  May, 2024 in Brussels, Belgium for the highly anticipated Clinical Trial Supply Forum.

Present your boss with this customizable letter detailing the reasons why you should attend Clinical Trial Supply Forum 2024 from 14 – 16 May, 2024 in Brussels, Belgium. Just download the letter template below, adjust as necessary (or edit as needed) and submit! We hope to welcome you there!

In an era where clinical trials are becoming increasingly complex and global, developing a robust supply strategy is more critical than ever. This strategic framework is designed to help you navigate the complex landscape of clinical trial supply, offering a step-by-step approach to crafting a resilient and adaptable strategy.

The clinical trial supply industry is going through a period of rapid change, propelled by the aftermath of the pandemic and the rapid evolution of technology. Additionally, world-changing geopolitical events continue to impact supply chains across all sectors. Ahead of the 2024 Clinical Trial Supply Forum, Pharma IQ interviewed Advisory Board member and Event Chairman, Steven Jacobs, President of Global BioPharm Solutions LLC, and we are pleased to take this opportunity to share with you our annual review of the trends and complexities that are shaping and driving transformation across the -end-to-end clinical trial supply chain.

Download the Report to Uncover:

• Expert Analysis on Industry Evolution: Gain invaluable insights into the profound transformation of the clinical trial supply landscape, emphasising the shift towards proactive, strategic supply chain models and the integration of cutting-edge technologies like AI and IoT.

• Impact of Global Challenges on Supply Chains: Learn how recent geopolitical events and the aftermath of the pandemic have driven innovation, emphasising the need for resilience and agility in overcoming supply chain disruptions.

• Technological Advancements in Supply Management: Explore the role of digital transformation in revolutionising supply chain management, with a focus on automation, predictive analytics, and real-time decision-making to ensure the success and integrity of clinical trials.

• Sustainability and Efficiency as Core Priorities: Delve into the growing emphasis on eco-friendly logistics and the optimisation of resource use, highlighting sustainable practices and efficiency improvements as key drivers of future industry success.

Discover the key highlights and learnings from the 2023 Clinical Trial Supply Forum in a concise, informative infographic format and understand what's shaping the future of the clinical trial supply industry. 

In the realm of clinical trials, patient recruitment poses a significant challenge, with merely 2%-5% of U.S. patients currently engaged in these crucial research endeavors. Patients represent the cornerstone of any clinical trial, without whom progress in developing novel therapies and advancing care innovation would stall. Consequently, ensuring patient participation and completion stands as a primary focus for clinical trial sponsors. While extensive research has been dedicated to understanding barriers to participation, such as access and indirect expenses like travel and lodging, another critical factor hindering participation and exacerbating patient drop-out emerges: the coverage of care for baseline or comparator drugs in the U.S., which contrasts with other countries like the U.K. where sponsors typically bear such costs. This disparity in coverage may disproportionately impact socio-economically vulnerable and diverse patient populations, potentially impeding their access to and engagement in vital clinical trials.

Dive into the whitepaper today to explore:

• The current state of care coverage in cancer trials
• Developing a framework to understand sponsor coverage impact
• Cost of noncoverage versus cost of coverage
• A case for coverage

The pharmaceutical sector loses billions of dollars annually due to logistical failures including temperature excursions and a lack of end-to-end visibility. The rapid shipment of vaccines worldwide to tackle Covid-19 highlighted the need for transport containers that adequately protect the medicines they are delivering. Since the pandemic began in 2020, additional factors such as a rise in demand for temperature-sensitive medicines, natural disasters and geopolitical factors have led to greater risk throughout supply chains, making them more vulnerable than ever before.

Alexandra Tsioni, Associate Director, Clinical Supply Chain Global Lead, Israel, brilliantly presented a 'Direct-to-Patient Case Study' at the Clinical Trial Supply Forum 2022. 

Download your copy to learn more about: 

• The impact of COVID-19 on clinical trials 
• Direct-to-patient vs traditional approaches 
• The impact on clinical supplies 
• Direct-to-patient case study considerations, challenges and mitigations

Building reverse logistics and product reconciliations into your supply strategy to optimise end to end distribution management was delivered at the Clinical Trial Supply Forum 2022 by Kamal Amin, Head of Supply Management, Galderma.

Download your copy to discover:

• The role of clinical supplies teams within the reverse logistics and reconciliations management strategy 
• Where your returns and reconciliations fit into your end-to-end clinical supply lifecycle
• Ways to reduce unforeseen costs through flexible product return and destruction strategies 
• End-to-end alignment in supply management by effectively engaging your clinical teams across the process implementation lifecycle